Celebrity Inventors
Actress Jamie Lee Curtis is a patented inventor - she created a diaper equipped with a premoistened baby wipe. And that's no act!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8182805 | Prevention of allergic sensitization The present invention relates to prevention and treatment of allergic sensitization and diseases associated therewith by treatment with an enterovirus vaccine, wherein the enterovirus does not contain an exogenous nucleic acid sequence that is integrated into the vi... | 05/22/2012 |
| 8101170 | Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof The invention relates to a probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive, comprising a mixture of microorganisms, selected from the group Enterococcus faecium, DSM 16211, Lactobacillus reuteri, DSM 16350... | 01/24/2012 |
| 8097244 | Human prostate cell lines in cancer treatment Combinations of cell lines are provided for allogeneic immunotherapy agents in the treatment of cancer. Cancer vaccines generally have been limited to the use of cells that contain at least some tumor specific antigens (“TSAs”) and/or tumor associated antigens (... | 01/17/2012 |
| 8080241 | Viruses for the treatment of cellular proliferative disorders Methods for treating cell proliferative disorders by administering virus to proliferating cells having an activated Ras-pathway are disclosed. The virus is administered so that it ultimately directly contacts proliferating cells having an activated Ras-pathway. Prol... | 12/20/2011 |
| 8071086 | Bacterial composition and its use The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacill... | 12/06/2011 |
| 8071087 | Reovirus for the treatment of cellular proliferative disorders Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include bu... | 12/06/2011 |
| 8066986 | Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms Disclosed are formulations for enhancing the in vivo colonization of probiotic microorganisms that include digestive enzymes and probiotic microorganisms, and polysorbate surfactants. The enzymes include lactogenic enzyme formulations that promote growth of Lacto... | 11/29/2011 |
| 8025874 | Bacillus strains useful for animal odor control A composition is provided that includes Bacillus subtilis 2084 (NRRL B-50013) or a strain having all of the identifying characteristics of the Bacillus subtilis 2084 (NRRL B-50013), B. subtilis 27 (NRRL B-50105) or a strain having all of the ide... | 09/27/2011 |
| 8021654 | Methods of treating pigs with strains Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are... | 09/20/2011 |
| 7939060 | Isoflavone-containing composition This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinic... | 05/10/2011 |
| 7923005 | Process for producing a bio-pesticide composition containing and A process for the production of organic and combination formulation of bio-pesticide containing Trichoderma harzianum and Pseudomonas fluorescens comprising preparation of mother culture, liquid fermentation as well as solid fermentation of T. harzi... | 04/12/2011 |
| 7862808 | Method for preventing or treating respiratory infections and acute otitis media in infants using LGG and Bb-12 The present invention is directed to a novel method for preventing or treating respiratory infections and acute otitis media in infants. The method comprises the administration of a therapeutically effective amount of a Bifidobacteria strain and an adherence-... | 01/04/2011 |
| 7740838 | Bacterial composition and its use The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacill... | 06/22/2010 |
| 7628981 | Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it Describes a new strain of Streptococcus thermophilus ssp. salivarius (deposited on 4 Dec. 2001 at the DSMZ—Deutsche Sammlung von Mikroorganismen und Zeilkulturen GmbH, Braunschweig, Germany, with accession No. DSM 14667) and edible compositions, drug... | 12/08/2009 |
| 7618623 | Hybrid adeno-retroviral vector for the transfection of cells An adenovirus, including adenoviral capsid proteins, and a replication-defective adenoviral vector that includes a 5′ retroviral LTR nucleic acid sequence, a 3′ retroviral LTR nucleic acid sequence, a nucleic acid sequence encoding a portion of a retroviral enve... | 11/17/2009 |
| 7524493 | Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension A method of inducing liver regeneration in a damaged liver tissue region of an individual is provided. The method including the step of providing at least two distinct growth factors to the damaged liver tissue region of the individual, at least one of the at least ... | 04/28/2009 |
| 7429477 | Controlling plant pathogens with bacterial/fungal antagonist combinations Fungal/bacterial antagonist combinations, a seed coated with one of the combinations and a plant protected from plant pathogens by one of the combinations. The invention is also a fungal/bacterial antagonist combination comprising a Trichoderma virens fungal ... | 09/30/2008 |
| 7429478 | Microbial consortium useful as seeding material for BOD analysis of pulp and paper industrial wastewater The present invention provides a seeding material for accurate and reproducible monitoring of BOD load of pulp and paper wastewater, wherein the bacteria are isolated from various locations in India and comprise Micrococcus sp., Staphylococcus sp., ... | 09/30/2008 |
| RE40457 | Enteral dietary compositions comprising a mixture of live lactic bacteria consisting of Streptococcus thermophilus, Bifidobacterium longum and Bifidobacterium infantis Enteral compositions containing a mixture of live lactic bacteria consisting of Streptococcus thermophilus, Bifidobacterium longum and Bifidobacterium infantis, each at a concentration equal to or greater than 1×1011 CFU per gram, are usefu... | 08/12/2008 |
| 7407794 | Biological control of plant diseases The present invention relates to the use of Ulocladium oudemansii as a biological control agent. Processes and compositions for the biological control of Botrytis species using Ulocladium oudemansii are also provided. ... | 08/05/2008 |
| 7384628 | Lactic acid bacteria and its use in direct-fed microbials A composition comprising lactic acid bacteria that are selected from at least one of Lactococcus lactis, Lactobacillus lactis, and Lactobacillus brevis. The composition is suitable for administration to animals. Upon administration to an animal, the co... | 06/10/2008 |
| 7368481 | Pet anti-aging wellness supplement for cats A health and nutrition supplement dosage for pets, particularly feline pets, consisting essentially of anti-oxidant vitamins, B complex vitamins, bioflavonoids, chelated minerals, digestive enzymes, herbs, nutrients, and essential fatty acids and amino acids. ... | 05/06/2008 |
| 7361354 | Methods for treating malignancies expressing ICAM-1 using coxsackie a group viruses There is disclosed a method of killing abnormal cells such as malignant cells including melanoma cells, using a virus recognizing at least one of a cell adhesion molecule and a complement regulatory protein. The virus may be a member of the Picornaviridae family. Co... | 04/22/2008 |
| 7354606 | Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors A nutritional supplement composition contains inhibitors of alpha-glucosidase and alpha-amylase substantially in the absence of lipase inhibitors. The composition can include touchi extract and phaseolamin as the alpha-glucosidase and alpha-amylase inhibitor, respec... | 04/08/2008 |
| 7354757 | strain Lactobacillus strains that have a genetic Profile I based on Apa I, Not I, and Xba I digests are provided. Preferably, the strains decrease level of at least one of coliforms and E. coli within the gastrointestinal tract of an animal. A direct-fed micr... | 04/08/2008 |
| 7345089 | Microbial method of making equol-containing composition and product made This invention provides a composition comprising a daidzein-containing substrate and a strain of micro-organism capable of metabolizing daidzein to equol as essential ingredients. This composition is effective in the prevention and alleviation of unidentified clinic... | 03/18/2008 |
| 7307062 | Method for treating a mental disorder A method of treating an individual exhibiting at least one symptom of a mental disorder is provided which comprises administering to the individual an antimicrobial composition in an amount effective to inhibit or eliminate the at least one symptom of the disorder. ... | 12/11/2007 |
| 7300650 | Reovirus for the treatment of neoplasia Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, and use of reovirus for manufacture of a medicament for the treatment of neoplasia, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the... | 11/27/2007 |
| RE39876 | Kit with enteral dietary composition consisting of Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum Enteral compositions containing Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum, each at a concentration equal to or greater than 1×1011 CFU per gram, are useful as adjuncts for enteral formulations and as oral nutritional... | 10/09/2007 |
| 7273605 | Vaccine The present invention relates to a fowlpox virus genome which has modifications in one or more wild-type FPV genes. The present invention also relates to a viral particle comprising such a genome and its use to deliver a nucleotide of interest (NOI) to a target cell... | 09/25/2007 |
| 7258866 | -containing ringworm vaccine A ringworm vaccine is disclosed comprising antigen isolated from at least one dermatophyte and a suitable carrier. The “antigen” can include a single antigen from a dermatophyte or a plurality of antigens as long as at least one antigen is included which will pr... | 08/21/2007 |
| 7252981 | Method for the preparation of stable and reusable biosensing granules The present invention provides a process for the preparation of stable and reusable biosensing granules useful in the assessment of biodegradability of effluents. The biosensing granules are prepared by culturing active aerobic microbial consortia in synthetic mediu... | 08/07/2007 |
| 7252836 | Food and feed compositions including resistant starch The invention described in this application relates to a method of increasing the amount of weight gained by the mammal during a feeding period, to a method of increasing the amount of milk replacer consumed by the mammal during a feeding period, to a method of decr... | 08/07/2007 |
| 7244435 | DNA vaccine expressing HA1 of equine-2 influenza virus The invention is for a DNA vaccine expressing the hemagglutinin (HA1) gene of equine-2 influenza virus. By engineering a stop codon within HA1, expression of HA1 is ensured. By encapsulation of the DNA vaccine in liposome and by intranasal inoculation, it is suffici... | 07/17/2007 |
| 7229616 | Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis The present invention relates to the use of a supernatant of lactic acid bacteria or of Bifidobacteria capable of preventing colonization of intestinal cells by Giardia intestinalis, for the preparation of an ingestible carrier for the treatment and/or prophy... | 06/12/2007 |
| 7226606 | Cancer-associated antigens and methods of their identification and use The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts wi... | 06/05/2007 |
| 7217421 | Cancer-associated antigens and methods of their identification and use The present invention provides novel, isolated, tumor-associated antigens, and methods for identifying such antigens in a biological sample, and of screening for the presence of such an antigen in a biological specimen, wherein the tumor antigen identified reacts wi... | 05/15/2007 |
| 7214370 | Prebiotic and preservative uses of oil-emulsified probiotic encapsulations Probiotic compositions derived from Lactobacillus casei ATCC number PTA 3945 are disclosed. More specifically, probiotic compositions containing prebiotic compositions including edible oils are provided. The probiotic/prebiotic compositions disclosed herein a... | 05/08/2007 |
| 7214788 | Insect inhibitory proteins, fusions, and methods of use therefor Novel insect inhibitory proteins are disclosed comprising two different components, both of which are required for biological activity. Various methods of linking both components together, so that a single protein provides insect inhibitory activity, are disclosed. ... | 05/08/2007 |
| RE39585 | Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons who are at increased risk for oxalate related disease because they have lost, or have inadequate co... | 04/24/2007 |
